Crinetics Pharmaceuticals Inc (CRNX)
56.76
+0.07
(+0.12%)
USD |
NASDAQ |
Nov 04, 13:06
Crinetics Pharmaceuticals Market Cap: 4.543B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 4.537B |
| October 31, 2024 | 4.479B |
| October 30, 2024 | 4.463B |
| October 29, 2024 | 4.503B |
| October 28, 2024 | 4.574B |
| October 25, 2024 | 4.639B |
| October 24, 2024 | 4.701B |
| October 23, 2024 | 4.674B |
| October 22, 2024 | 4.771B |
| October 21, 2024 | 4.698B |
| October 18, 2024 | 4.729B |
| October 17, 2024 | 4.716B |
| October 16, 2024 | 4.711B |
| October 15, 2024 | 4.610B |
| October 14, 2024 | 4.250B |
| October 11, 2024 | 4.253B |
| October 10, 2024 | 4.144B |
| October 09, 2024 | 4.058B |
| October 08, 2024 | 4.138B |
| October 07, 2024 | 4.143B |
| October 04, 2024 | 4.253B |
| October 03, 2024 | 4.223B |
| October 02, 2024 | 4.324B |
| October 01, 2024 | 4.155B |
| September 30, 2024 | 4.090B |
| Date | Value |
|---|---|
| September 27, 2024 | 4.062B |
| September 26, 2024 | 4.048B |
| September 25, 2024 | 4.038B |
| September 24, 2024 | 3.987B |
| September 23, 2024 | 4.035B |
| September 20, 2024 | 4.254B |
| September 19, 2024 | 4.312B |
| September 18, 2024 | 4.223B |
| September 17, 2024 | 4.241B |
| September 16, 2024 | 4.317B |
| September 13, 2024 | 4.306B |
| September 12, 2024 | 4.100B |
| September 11, 2024 | 4.061B |
| September 10, 2024 | 4.034B |
| September 09, 2024 | 4.181B |
| September 06, 2024 | 4.033B |
| September 05, 2024 | 4.080B |
| September 04, 2024 | 4.226B |
| September 03, 2024 | 4.163B |
| August 30, 2024 | 4.247B |
| August 29, 2024 | 4.218B |
| August 28, 2024 | 4.354B |
| August 27, 2024 | 4.360B |
| August 26, 2024 | 4.251B |
| August 23, 2024 | 4.254B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
283.01M
Minimum
Mar 16 2020
4.771B
Maximum
Oct 22 2024
1.353B
Average
946.08M
Median
Aug 08 2023
Market Cap Benchmarks
| PTC Therapeutics Inc | 3.137B |
| Zevra Therapeutics Inc | 454.62M |
| Clearside Biomedical Inc | 76.99M |
| Biomea Fusion Inc | 325.42M |
| NovaBay Pharmaceuticals Inc | 3.652M |
Market Cap Related Metrics
| PEG Ratio | -1.384 |
| Price to Book Value | 5.468 |
| Price | 56.76 |
| Earnings Yield | -6.66% |
| PEGY Ratio | -1.384 |